Company Filing History:
Years Active: 1996-1997
Title: Matthias Herboth: Innovator in Pharmaceutical Technologies
Introduction
Matthias Herboth is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 2 patents, his work focuses on enhancing the efficacy and stability of pharmaceutical preparations.
Latest Patents
Herboth's latest patents include groundbreaking inventions that address critical challenges in drug formulation. One of his notable patents is for "Injectable liposomal pharmaceutical preparations." This invention relates to stable liposomal injectable formulations for lipophilic, poorly soluble active compounds, specifically targeting active compounds from the dihydropyridines group. Another significant patent is for a "Device for inhalation." This device is designed for the inhalation of a powdery, pharmacologically active drug and features a supply container, a metering unit, and a unique V-shaped air inlet channel that enhances the inhalation process.
Career Highlights
Matthias Herboth is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to contribute to the development of innovative solutions that improve patient outcomes. His expertise in pharmaceutical formulations has positioned him as a key player in the industry.
Collaborations
Throughout his career, Herboth has collaborated with talented professionals, including Heiko Herold and Axel Wollenschlager. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of cutting-edge technologies.
Conclusion
Matthias Herboth's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the challenges in the field and a dedication to finding effective solutions. His work continues to influence the pharmaceutical industry positively.